Navitoclax | Combined | Patients | Disease | Outcomes | ORR | Stabilized | Ref |
---|---|---|---|---|---|---|---|
NCT00888108 | DOC | 39/41 Pre-Treated | AST | MTD | 4/35 PR | – | [392] |
NCT01009073 | ERLO | – | NSCLC, PC, SCC | MTD | 0% ORR | 27% | [393] |
NCT00887757 | GEM | Pre-Treated | ST | MTD | 0% ORR | 54% | [394] |
NCT00891605 | CARB/PAC | – | ST | TERMINATED | 5.3% PR | 36.80% | [395] |
NCT00878449 | ETOP/CISP | Untreated (14 days) | SCLC | MTD | – | – | [396] |
NCT00445198 | -single- | Pre-Treated | NSCLC, ST | 0% | 1/47 PR | 22.8% (13 m) | [390] |
NCT00406809 | -single- | – | LM | MTD | 10/46 PR | – |